Daejeon, South Korea

Chul-Joong Kim


Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Daejeon-si, KR (2005 - 2008)
  • Daejeon, KR (2007 - 2011)
  • Yuseong-gu, KR (2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovative Contributions of Chul-Joong Kim in Peptide Antibiotics and Vaccines

Introduction

Chul-Joong Kim is a distinguished inventor based in Daejeon, South Korea. With a remarkable portfolio of 7 patents, he has made significant strides in the fields of biotechnology and pharmaceuticals. His innovations primarily focus on developing methods for surface expression of peptide antibiotics and enhancing vaccine delivery mechanisms.

Latest Patents

Among his latest patents are groundbreaking methods for expressing peptide antibiotics, namely P5 and Anal3. These antibiotics exhibit amphiphilicity and show considerable antibacterial, antifungal, and anticancer activities. His invention details a method for expressing these peptides on microbial surfaces using vectors containing outer membrane protein genes derived from certain bacterial strains involved in the synthesis of poly-gamma-glutamate. This innovative approach allows for mass production of peptide antibiotics without the need for purification, highlighting its high industrial applicability.

In addition, another noteworthy patent involves the development of expression vectors for an anti-HPV vaccine. The vectors efficiently produce virion capsid proteins and tumor-associated proteins of the human papillomavirus on microbial surfaces. Chul-Joong Kim's method includes bacterial strains that harbor these surface display vectors, potentially leading to enhanced vaccine efficacy.

Career Highlights

Chul-Joong Kim has worked with notable organizations such as Bioleaders Corporation and the Korea Research Institute of Bioscience and Biotechnology. His contributions have propelled advancements in biotechnology, contributing to both industrial practices and healthcare improvements.

Collaborations

During his career, Chul-Joong Kim has collaborated with esteemed colleagues such as Moon-Hee Sung and Seung-Pyo Hong. These partnerships have fostered a conducive environment for innovative research and development within the field of microbiology and biotechnology.

Conclusion

Chul-Joong Kim's inventive achievements have made a significant impact in the domains of peptide antibiotics and vaccine technology. His contributions not only improve the efficacy of medical treatments but also pave the way for future innovations that could revolutionize healthcare practices. Through his work, he exemplifies the spirit of innovation that drives progress in scientific research and application.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…